Shree Ganesh Biotech India Ltd

A sharp decline in the share price has dragged Shree Ganesh Biotech India Ltd to a fresh 52-week low of Rs 0.52 on 11 Jun 2026, marking a 34.83% drop over the past year and signalling sustained pressure on this micro-cap pharmaceutical stock.

Shree Ganesh Biotech India Ltd’s stock price declined to an all-time low of ₹0.58 on 11 June 2026, marking a significant milestone in its ongoing downward trajectory. The company’s shares have underperformed considerably against the broader market and its sector peers, reflecting persistent financial and valuation pressures.

Shree Ganesh Biotech India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Aug 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Shree Ganesh Biotech India Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹24.32 crores, reported a net loss of ₹0.15 crores in Q4 FY26 (Mar'26), marking a sharp deterioration from the ₹0.32 crores profit posted in the previous quarter. The stock, currently trading at ₹0.61, has declined 34.41% over the past year, significantly underperforming the broader market and reflecting mounting investor concerns over the company's operational viability.

Shree Ganesh Biotech India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Aug 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

The micro-cap pharmaceutical company Shree Ganesh Biotech India Ltd has plunged to a fresh all-time low of Rs.0.54 on 1 Apr 2026, extending a multi-year decline that has seen its share price lose over 90% in the past five years. Despite a modest rebound in recent sessions, the stock remains deeply undervalued and faces significant headwinds across valuation and financial metrics.

The micro-cap pharmaceutical stock Shree Ganesh Biotech India Ltd has plunged to an all-time low of Rs 0.54 on 30 Mar 2026, marking a fresh nadir amid a prolonged downtrend that has seen the share price lose nearly 39% over the past year.

The shares of Shree Ganesh Biotech India Ltd have plunged to an all-time low of Rs 0.54 on 25 Mar 2026, extending a steep decline that has seen the stock lose over 43% in the past year despite a flat recent financial performance.

Shree Ganesh Biotech India Ltd’s shares touched a new 52-week low of Rs.0.54 today, marking a significant decline amid ongoing financial pressures and subdued market sentiment within the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Biotech India Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week and all-time low price of Rs.0.54, marking a significant decline in its stock value over the past year.

Shree Ganesh Biotech India Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new all-time low of Rs.0.54, marking a significant milestone in its ongoing downward trajectory. The stock’s recent performance highlights persistent difficulties reflected in its financial and market metrics.

Shree Ganesh Biotech India Ltd’s stock has declined to an all-time low, closing just 3.51% above its 52-week low of Rs 0.55 on 16 Mar 2026. The micro-cap pharmaceutical and biotechnology company continues to face significant headwinds, reflected in its deteriorating financial metrics and sustained negative returns over multiple time horizons.

Shree Ganesh Biotech India Ltd has touched a new 52-week and all-time low of Rs.0.55, marking a significant decline in its stock price amid broader market pressures and company-specific financial concerns.

Shares of Shree Ganesh Biotech India Ltd have declined to an all-time low, reflecting a sustained period of underperformance within the Pharmaceuticals & Biotechnology sector. The stock closed just 1.75% above its 52-week low of Rs 0.56, marking a significant milestone in its downward trajectory amid broader market pressures and company-specific financial strains.

Shree Ganesh Biotech India Ltd has touched a new 52-week and all-time low of Rs.0.56 today, marking a significant decline in its stock price amid broader market pressures and company-specific financial concerns.